Metraipolis › archive › dc_4e7a25003702

The protective efficacy of baricitinib against lipopolysaccharide / D-Galactosamine-Induced acute liver Injury — Europe PMC PMID:42488570

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42488570
DOI
10.3389/fphar.2026.1848559
License (as archived)
solo-consultazione
Archived
2026-10-18T09:58:02.281Z
SHA-256 of the archived text
f1ed9afa491ad5d766dff191d4d3900553d37c7339ac4c8c634dc126ad7e071e
Stable URL of this page
https://metraipolis.com/documento/dc_4e7a25003702

How to cite

The protective efficacy of baricitinib against lipopolysaccharide / D-Galactosamine-Induced acute liver Injury — Europe PMC PMID:42488570 — Europe PMC (en), https://europepmc.org/article/MED/42488570 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e7a25003702 (Metraipolis archive dc_4e7a25003702, sha256 f1ed9afa491ad5d766dff191d4d3900553d37c7339ac4c8c634dc126ad7e071e)
BibTeX
@misc{dc4e7a25003702,
  title = {The protective efficacy of baricitinib against lipopolysaccharide / D-Galactosamine-Induced acute liver Injury — Europe PMC PMID:42488570},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42488570},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e7a25003702; sha256 f1ed9afa491ad5d766dff191d4d3900553d37c7339ac4c8c634dc126ad7e071e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42488570. Agents can read the archived copy with the MCP tool read_document.